{"id":"W1996353873","doi":"10.1016/j.urolonc.2013.01.005","title":"Treatment options in castration-resistant prostate cancer: Current therapies and emerging docetaxel-based regimens","year":2013,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Docetaxel; Enzalutamide; Cabazitaxel; Medicine; Prostate cancer; Dasatinib; Oncology; Clinical trial; Internal medicine; Abiraterone acetate; Pharmacology; Cancer; Androgen receptor; Androgen deprivation therapy; Tyrosine kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009987392,0.0002669974,0.0005890275,0.0003829081,0.0004575959,0.001404846,0.0005107197,0.0004624153,0.002547513],"category_scores_gemma":[0.0006450422,0.0001168855,0.000433989,0.0006787025,0.0007976817,0.001637207,0.0006496459,0.001995658,0.0003266017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00110753,"about_ca_system_score_gemma":0.001195282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001304887,"about_ca_topic_score_gemma":0.007380553,"domain_scores_codex":[0.9997758,0.00006175643,0.0000199277,0.00003251758,0.00005924949,0.00005076652],"domain_scores_gemma":[0.9997318,0.00009692153,0.00005606157,0.00001288132,0.0000450825,0.00005732736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00137967,0.0003469477,0.003702059,0.002397899,0.000131023,0.0008727349,0.0002740395,0.002141249,0.006598636,0.01832493,0.03177106,0.9320598],"study_design_scores_gemma":[0.0007163224,0.002241307,0.01913465,0.004365754,0.0004492363,0.006267067,0.001163931,0.002835397,0.005263604,0.02012889,0.9373374,0.00009648289],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01556348,0.9523051,0.001776552,0.020468,0.001077,0.00002684496,0.00005760134,0.00002575801,0.008699697],"genre_scores_gemma":[0.1451222,0.8332708,0.004848969,0.007867459,0.003273761,0.00006669122,0.0001865033,0.00002564671,0.005337934],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002547513,"threshold_uncertainty_score":0.008522272,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03581451240196135,"score_gpt":0.3452954380920764,"score_spread":0.3094809256901151,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}